1. PAR4: A new role in the modulation of visceral nociception
- Author
-
Sylvie Bradesi
- Subjects
Agonist ,TRPV4 ,medicine.medical_specialty ,Colon ,Physiology ,medicine.drug_class ,Visceral Afferents ,Pain ,TRPV Cation Channels ,Inflammation ,Irritable Bowel Syndrome ,Mice ,Transient receptor potential channel ,Internal medicine ,medicine ,Animals ,Humans ,Receptor, PAR-2 ,Receptor ,Irritable bowel syndrome ,Endocrine and Autonomic Systems ,business.industry ,Gastroenterology ,Visceral pain ,medicine.disease ,Endocrinology ,Nociception ,Receptors, Thrombin ,medicine.symptom ,business - Abstract
Protease-activated receptors (PARs) are a family of G-protein-coupled receptors with a widespread distribution that are involved in various physiological functions including inflammation and nociception. In a recent study in Neurogastroenterology and Motility, Augé et al. describe for the first time the presence of PAR4 on visceral primary afferent neurons and its role in modulating colonic nociceptive responses, colonic hypersensitivity and primary afferent responses to PAR2 and Transient Receptor Potential Vanilloid-4 (TRPV4). Using the model of visceromotor response (VMR) to colorectal distension (CRD), they show that a PAR4 agonist delivered into the colon lumen decreases basal visceral response to CRD and reduces the exacerbated VMR to CRD induced by treatment with PAR2 or TRPV4 agonists. In isolated sensory neurons, they show that a PAR4 agonist inhibits calcium mobilization induced by PAR2 or TRPV4 agonists. Finally, they describe increased pain behaviour evoked by luminal application of mustard oil in PAR4 deficient mice compared to wild type controls. The newly discovered role of PAR4 in modulating visceral pain adds to our growing understanding of the contribution of colonic proteases and PARs to the mechanisms involved in colonic hypersensitivity and their potential role as therapeutic targets for irritable bowel syndrome.
- Published
- 2009
- Full Text
- View/download PDF